WELLS FARGO & COMPANY/MN - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 40 filers reported holding SAB BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$169
-17.6%
268
+8.5%
0.00%
Q2 2023$205
+150.0%
247
+32.1%
0.00%
Q1 2023$82
-24.8%
187
+1.1%
0.00%
Q4 2022$109185
+2.8%
0.00%
Q3 2022$0180
+7.8%
0.00%
Q2 2022$01670.00%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 78,115$294,0000.05%
Shaolin Capital Management LLC 275,000$1,034,0000.03%
Spectrum Management Group, LLC 5,030$19,0000.00%
Veritable, L.P. 43,551$164,0000.00%
ALPS ADVISORS INC 45,083$170,0000.00%
ETF MANAGERS GROUP, LLC 13,187$34,0000.00%
Qube Research & Technologies Ltd 24,179$91,0000.00%
NORTHERN TRUST CORP 44,476$167,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 301,110$1,132,0000.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders